License

LithiumBank Announces Intellectual Property License Agreement with G2L Greenview Resources Inc. for Direct Lithium Extraction Technology, Pilot Plant Testing and Commercialization

Retrieved on: 
Monday, September 11, 2023
Area studies, Association of Professional Engineers and Geoscientists of Alberta, DLE, TSX Venture Exchange, Donald Duck filmography, First Milestone, Sustainability Accounting Standards Board, Porosity, ASX, Consultant, APEGBC, End-user license agreement, Terminate, QP, CNQ, APEGA, National instrument, Engineering, Water, Economic development, Indian stock exchange, License, OPEX, Federation, CGI, News, NYSE, Economics, Lithium, Oil, Security (finance), Lease, Boardwalk

CALGARY, Alberta, Sept. 11, 2023 (GLOBE NEWSWIRE) -- LithiumBank Resources Corp. (TSX-V: LBNK) (OTCQX: LBNKF) (“LithiumBank'' or the “Company”) is pleased to announce it has entered into an intellectual property license agreement on September 8th 2023 (the “Agreement”) with G2L Greenview Resources Inc. (“G2L”), a subsidiary of Go2Lithium Inc., whereby G2L shall grant to the Company a license (the “License”) in Alberta and Saskatchewan for a full suite of continuous ion exchange technologies (the “Licensed Technology”). The Direct Lithium Extraction (“DLE”) technology will be used to extract lithium salts from enriched brines present at the Company’s lithium development projects.

Key Points: 
  • This update will include the G2L test work results and the effects of the Canadian federal government incentive tax credits for lithium brine processing.
  • G2L will also provide the Company with access to a deployment-ready pilot plant that has been previously operating in Australia.
  • Modifications to the pilot plant are almost complete and it is expected to be shipped in October to Alberta.
  • “This licensing agreement with G2L provides LithiumBank with access to best-in-class direct lithium extraction technology that we expect to have a significant impact on the economics of our Alberta projects,” said Paul Matysek, Executive Chairman of LithiumBank.

Ovation Science Signs License Agreement with Planet 13 for Its Topical / Transdermal Cannabis Products for Nevada

Retrieved on: 
Monday, September 11, 2023
Partnership, CSE, Planet 13 Holdings, Food, Cannabinoid, Research, LAS, Criticism of the Food and Drug Administration, Patient, Specialty store, License, End-user license agreement, THC, Skin, Disease, Pharmaceutical industry, Drug, CBD

Under the terms of the agreement, Planet 13 will have the exclusive manufacturing, sales and marketing rights for Ovation's topical / transdermal products for Nevada.

Key Points: 
  • Under the terms of the agreement, Planet 13 will have the exclusive manufacturing, sales and marketing rights for Ovation's topical / transdermal products for Nevada.
  • Planet 13 owns and operates the world's largest cannabis dispensary that has become a must-see destination for cannabis connoisseurs and tourists from around the world.
  • Planet 13 accounts for just under 9-percent of cannabis dispensary revenue for the entire state of Nevada.
  • "We are very pleased to reach this agreement with Planet 13, said Terry Howlett, President of Ovation.

Wolverine Worldwide Continues Brand Portfolio Transformation

Retrieved on: 
Friday, September 1, 2023
Fashion, Supply Chain Management, Footwear, Online Retail, Retail, Catalog, Hush, Wolverine World Wide, Hush Puppies, DSW, Sale, NYSE, Wolverine, License, New Balance

Wolverine World Wide, Inc. (NYSE: WWW) today announced additional steps in the ongoing transformation of its brand portfolio, including the sale of the Hush Puppies intellectual property in China, Hong Kong, and Macau, and the sale of the U.S. Wolverine Leathers business.

Key Points: 
  • Wolverine World Wide, Inc. (NYSE: WWW) today announced additional steps in the ongoing transformation of its brand portfolio, including the sale of the Hush Puppies intellectual property in China, Hong Kong, and Macau, and the sale of the U.S. Wolverine Leathers business.
  • “These transactions are the latest actions in our ongoing effort to reshape our portfolio and target our most meaningful opportunities,” said Mike Stornant, Executive Vice President and Chief Financial Officer of Wolverine Worldwide.
  • Wolverine will continue to own and operate the Hush Puppies brand throughout the rest of the world.
  • The Company assigned Wolverine’s U.S. tannery contracts to New Balance, and continues to explore alternatives for the non-U.S. Wolverine Leathers business.

Proton Capital Announces Strategic Alliance Agreement With PharmaChoice Canada Inc.

Retrieved on: 
Thursday, August 31, 2023
Letter, Strategic alliance, Pharmacy, Qualification, ROFR, TSX Venture Exchange, Sale, End-user license agreement, Name, Acquisition, License, Simpson, Health, News, Potential, Real estate, Commercial property, Proton

REGINA, Saskatchewan, Aug. 31, 2023 (GLOBE NEWSWIRE) -- PROTON CAPITAL CORP. (“Proton”) (PTN.P-TSX-V), further to its news releases dated April 20, 2023 and July 26, 2023 in relation to the signing of a Letter of Intent dated April 20, 2023 with PharmaChoice Canada Inc., and the potential qualifying transaction of Proton (“Qualifying Transaction”), Proton is pleased to report that the definitive agreements in relation to a strategic alliance (“Strategic Alliance Agreement”) with PharmaChoice Canada Inc. have been executed.

Key Points: 
  • REGINA, Saskatchewan, Aug. 31, 2023 (GLOBE NEWSWIRE) -- PROTON CAPITAL CORP. (“Proton”) (PTN.P-TSX-V), further to its news releases dated April 20, 2023 and July 26, 2023 in relation to the signing of a Letter of Intent dated April 20, 2023 with PharmaChoice Canada Inc., and the potential qualifying transaction of Proton (“Qualifying Transaction”), Proton is pleased to report that the definitive agreements in relation to a strategic alliance (“Strategic Alliance Agreement”) with PharmaChoice Canada Inc. have been executed.
  • In addition, the Strategic Alliance Agreement includes, but is not limited to, the following schedules which have been executed but are being held in escrow until the completion of the Qualifying Transaction: a license agreement (“License Agreement”), a right-of-first-refusal agreement (“ROFR”) and a master membership agreement (“Master Membership Agreement”).
  • Alan Simpson, CEO of Proton stated, “We are excited about our strategic alliance with PharmaChoice Canada Inc. and our entry into the pharmacy business upon completion of the Qualifying Transaction.
  • This strategic alliance provides long term sustainability for PharmaChoice Canada Inc. and its members and offers Proton a great pipeline of acquisitions for the foreseeable future.

Femasys Inc. Obtains Medical Device Establishment License from Health Canada

Retrieved on: 
Thursday, August 31, 2023
Medical device, Woman, Infertility, Cervical cancer, Diagnosis, License, Health Canada

ATLANTA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with two lead revolutionary product candidates in late-stage clinical development for reproductive health in addition to innovative diagnostic products constituting a broad portfolio of in-office accessible solutions, today announced that it has obtained a Medical Device Establishment License (“MDEL”) from Health Canada (License Number 24825).

Key Points: 
  • ATLANTA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with two lead revolutionary product candidates in late-stage clinical development for reproductive health in addition to innovative diagnostic products constituting a broad portfolio of in-office accessible solutions, today announced that it has obtained a Medical Device Establishment License (“MDEL”) from Health Canada (License Number 24825).
  • The MDEL license is issued by Health Canada’s Regulatory Operations and Enforcement Branch (ROEB) to companies for the activities of manufacturing, importing and distributing and selling of medical devices for human use in Canada.
  • This license allows Femasys to directly sell its four products, FemaSeed®, FemVue®, FemCath® and FemCerv®, approved in Canada.
  • “We are thrilled to provide women in Canada access to Femasys’ medical products for infertility treatment and diagnosis, as well as cervical cancer diagnosis.”
    More information on Femasys’ approved products in Canada (FemaSeed, FemVue, FemCath and FemCerv) is below:

Excellence in Digital Commerce - Finding the Best in Class

Retrieved on: 
Wednesday, August 23, 2023
Central Bank of Brazil, Bronze, FIS, Advanced technology, Visa, News, Platform as a service, Carat, Secured loan, Prince Sultan Advanced Technology Research Institute, Service, License, CNBC, Russell, IBA, Yoy, Astoria, SMS, Mobile payment, IP, Length, Silicon, Mastercard, Statista, Software as a service, Partnership, Nu, Directory, Kora (Fintech company), Gerald Celente, Cryptocurrency, Pharmaceutical industry, Online shopping, Mobile phone, Bank, Fiserv, Fintech, Growth, Nubank

Looking at recent news highlights from some of the industry's recognized leaders, innovation and a passion for being best in class are driving growth for the sector.

Key Points: 
  • Looking at recent news highlights from some of the industry's recognized leaders, innovation and a passion for being best in class are driving growth for the sector.
  • Its mission is to streamline, simplify, digitize, and automate back-office financial processes while transforming digital payments through an all-in-one Fintech platform.
  • From the news: Fiserv was recognized in the Digital Payments Category for the depth and breadth of capabilities it provides merchants and financial institutions, including solutions that enable digital commerce, digital money transfers, and mobile payments.
  • For investors watching key trends, the banking industry is going through a digital transformation and evolution and the drive for excellence is in full gear.

Red White & Bloom Provides Update Relating to Aleafia Health

Retrieved on: 
Tuesday, August 22, 2023
Companies' Creditors Arrangement Act, License, Ontario Superior Court of Justice, Maintenance, CSE, Senior, CCAA, IP, Sale, Date, Stalking, Documentation, RWB, OTC, Monitor, Security (finance), Auction, Court

TORONTO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) is providing an update on matters relating to Aleafia Health Inc. (“Aleafia Health”).

Key Points: 
  • TORONTO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) is providing an update on matters relating to Aleafia Health Inc. (“Aleafia Health”).
  • Certain excluded assets and liabilities of the Aleafia Purchased Entities would be transferred to one or more corporations that would not be included among the Aleafia Purchased Entities at closing.
  • RWB’s subsidiary would be the sole shareholder of the Aleafia Purchased Entities following closing.
  • The entering into the Stalking Horse Agreement was evaluated and ultimately approved by the disinterested members of the board of directors of each of Aleafia Health and RWB.

McCann School of Business & Technology in Lewisburg to Launch CDL: Class A Tractor-Trailer Training Program

Retrieved on: 
Tuesday, August 22, 2023
Bureau of Labor Statistics, Ancora, Driver's licenses in the United States, McCann School of Business & Technology, CDL, Business, License, Student, Commercial, Heavy equipment

LEWISBURG, Pa., Aug. 22, 2023 /PRNewswire/ -- The McCann School of Business & Technology at Lewisburg, a part of the Ancora network of vocational schools and a leading workforce training provider, is set to launch a Commercial Drivers License (CDL): Class A tractor-trailer training program September 18, 2023, that will prepare students to sit for the exam to obtain a CDL. Obtaining a Class A Commercial Driver's License allows for a career in heavy haul and tractor-trailer truck driving.

Key Points: 
  • LEWISBURG, Pa., Aug. 22, 2023 /PRNewswire/ -- The McCann School of Business & Technology at Lewisburg , a part of the Ancora network of vocational schools and a leading workforce training provider, is set to launch a Commercial Drivers License (CDL): Class A tractor-trailer training program September 18, 2023, that will prepare students to sit for the exam to obtain a CDL.
  • Obtaining a Class A Commercial Driver's License allows for a career in heavy haul and tractor-trailer truck driving.
  • "We are thrilled to add the CDL Class A Tractor-Trailer program at our campus and for our local community," said Jessica Rohrbach, Executive Director at McCann Lewisburg.
  • The CDL: Class A Tractor-Trailer program offers a balance between classroom learning and on-the-road training to prepare participants for the Commercial Driver licensing exam.

AppTech Payments Corp. Reports Second Quarter 2023 Results

Retrieved on: 
Monday, August 14, 2023
Partnership, Russell Microcap Index, Bank statement, Mobile payment, Fintech, License, Visa, Silicon, Russell, Mastercard, SMS, Cryptocurrency, Mobile phone, Broadnet Holdings BV

CARLSBAD, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (“AppTech”) (NASDAQ: APCX), an innovative Fintech company powering seamless commerce between businesses and consumers, today announced results for its second quarter ended June 30, 2023.

Key Points: 
  • CARLSBAD, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (“AppTech”) (NASDAQ: APCX), an innovative Fintech company powering seamless commerce between businesses and consumers, today announced results for its second quarter ended June 30, 2023.
  • Revenue was approximately $134 thousand for the three months ended June 30, 2023, up 9% compared to $123 thousand for the three months ended June 30, 2022.
  • Revenue was approximately $223 thousand for the six months ended June 30, 2023, compared to $227 thousand for the prior-year period.
  • Luke D’Angelo, Chief Executive Officer of AppTech, commented: “In the second quarter, we continued to leverage our powerful and differentiated Fintech platform, while the value of our patent portfolio is increasingly being recognized by the market.

SCYNEXIS Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Monday, August 14, 2023
Workforce, Mucorales, GSK, Hansoh Pharmaceutical, IV, SG, Ibrexafungerp, General Administration of Sport of China, Biotechnology, NDA, NIH, Candidiasis, Global health, Tablet, End-user license agreement, Silicon, Congress, Antimalarial medication, ECCMID, VVC, Investment, European, License, Research, IND, NMPA, Infection, Auris, FURI, Pharmaceutical industry, Cryptocurrency

JERSEY CITY, N.J., Aug. 14, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX ), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the second quarter ended June 30, 2023.

Key Points: 
  • JERSEY CITY, N.J., Aug. 14, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX ), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the second quarter ended June 30, 2023.
  • On June 21, 2023, SCYNEXIS announced the achievement of a $25 million performance-based development milestone under its exclusive license agreement with GSK for ibrexafungerp.
  • Selling, general & administrative (SG&A) expense for Q2 2023 decreased to $7.5 million from $15.8 million for Q2 2022.
  • Total other income was $5.7 million for Q2 2023, versus total other income of $8.4 million for Q2 2022.